• LAST PRICE
    8.4700
  • TODAY'S CHANGE (%)
    Trending Up0.0200 (0.2367%)
  • Bid / Lots
    8.4500/ 2
  • Ask / Lots
    8.5000/ 3
  • Open / Previous Close
    8.3800 / 8.4500
  • Day Range
    Low 8.1300
    High 8.5950
  • 52 Week Range
    Low 6.5100
    High 33.4100
  • Volume
    56,772
    below average

Search Criteria

Filter search criteria using below inputs

Click on magnifying glass icon to search

Search Criteria - - - Stocks (0)
CompanyCountrySymbol
Select an index
Price Comparison Graph. See accessible table below
1 Day Comparison Chart Accessibility Table. Friday's close: 8.45
TimeVolumeAMLX
09:32 ET6448.53
09:36 ET25508.225
09:38 ET1008.13
09:39 ET8008.24
09:45 ET2008.23
09:48 ET2008.14
09:50 ET1008.13
09:59 ET2008.25
10:10 ET6508.27
10:12 ET12008.36
10:21 ET53928.4301
10:24 ET3008.5
10:26 ET16508.45
10:28 ET20708.495
10:30 ET2008.54
10:32 ET11008.56
10:33 ET5388.53
10:35 ET1008.48
10:37 ET1008.4
10:39 ET1008.3775
10:44 ET1008.385
10:46 ET1008.36
10:48 ET4008.37
10:50 ET6008.39
10:53 ET3008.36
11:00 ET7008.34
11:02 ET2008.32
11:04 ET14008.31
11:06 ET1008.31
11:09 ET2008.38
11:11 ET5008.415
11:13 ET3008.42
11:15 ET1008.41
11:18 ET1008.46
11:20 ET3008.47
11:26 ET1008.48
11:27 ET4998.49
11:29 ET2008.42
11:31 ET1008.45
11:38 ET8008.5
11:40 ET1008.5
11:42 ET9008.4812
11:45 ET3008.49
11:47 ET1008.4825
11:49 ET5008.53
11:51 ET5008.52
12:00 ET2008.56
12:03 ET3058.56
12:14 ET11518.52
12:16 ET1008.46
12:25 ET1008.44
12:27 ET1008.43
12:30 ET3008.45
12:32 ET1008.47
12:34 ET1008.48
12:36 ET13338.455
12:38 ET5018.44
12:41 ET19008.395
12:43 ET2008.38
12:45 ET2008.375
12:48 ET5008.42
12:52 ET3008.41
12:57 ET1018.445
12:59 ET1018.445
01:06 ET5008.47
01:10 ET1008.5
01:12 ET1008.51
01:14 ET1008.52
01:28 ET40748.445
01:42 ET2008.47
01:55 ET37228.47
02:00 ET22948.44
02:04 ET4748.4584
02:06 ET6008.47
Data delayed at least 15 minutes.
Industry Peers Overview Table
Company sortableMarket Cap sortableP/E Ratio (TTM) sortableEPS Growth (5yr) sortable
United StatesAMLX
Amylyx Pharmaceuticals Inc
396.4M
-5.4x
---
United StatesOCGN
Ocugen Inc
394.7M
-6.0x
---
United StatesPRAX
Praxis Precision Medicines Inc
398.2M
-2.8x
---
United StatesNAUT
Nautilus Biotechnology Inc
402.0M
-8.3x
---
United StatesNUVL
Nuvalent Inc
389.4M
-5.3x
---
United StatesINO
Inovio Pharmaceuticals Inc
401.4M
-1.3x
---
As of 2022-05-16

Company Information

Amylyx Pharmaceuticals, Inc. is a clinical-stage biopharmaceutical company. The Company is developing therapies for treatment paradigm for amyotrophic lateral sclerosis (ALS), and range of neurodegenerative diseases by keeping neurons alive. The Company is pursuing commercialization of its product candidate, AMX0035. AMX0035 is an investigational product comprised of two complementary active agents, sodium phenylbutyrate (PB) and taurursodiol (TURSO) also known as ursodoxicoltaurine. AMX0035 is designed to target the endoplasmic reticulum and mitochondrial-dependent neuronal degeneration pathways in ALS and other neurodegenerative diseases. AMX0035 keep neurons alive under a variety of different conditions and stresses, including in in vitro models of neurodegeneration, endoplasmic reticulum stress, mitochondrial dysfunction, oxidative stress and disease-specific models of a variety of other conditions, as well as in vivo models of Alzheimer’s Disease (AD) and multiple sclerosis.

Contact Information

Headquarters
43 THORNDIKE STREETCAMBRIDGE, MA, United States 02141
Phone
617-682-0917
Fax
302-636-5454

Executives

Independent Non-Executive Chairman of the Board
George Milne
Co-Chief Executive Officer, Director
Joshua Cohen
Co-Chief Executive Officer, Director
Justin Klee
Chief Financial Officer
James Frates
Chief Commercial Officer
Margaret Olinger

Our Ratings feature offers company-specific research ratings from providers such as First Call, S&P and Argus.

Open a New Account, or Login if you're a client.

You have access to a comprehensive selection of independent research reports from providers such as TD Securities, S&P, INK, and Argus.

Open a New Account, or Login if you're a client.

Fundamentals Table
Market Cap
$396.4M
Revenue (TTM)
$285.0K
Shares Outstanding
57.9M
Dividend Yield
0.00%
Annual Dividend Rate
---
Ex-Dividend Date
01-01-01
Pay Date
01-01-01
Beta
---
EPS
$-1.56
Book Value
$1.56
P/E Ratio
-5.4x
Price/Sales (TTM)
1,390.8
Price/Cash Flow (TTM)
---
Operating Margin
-29,013.33%
*GAAP = prior to non-GAAP analyst adjusted earnings.

Our Calendar feature allows you to view a wide selection of market and company events, including earnings, dividends, splits, rating changes, guidance, and more. Access past, current and future events in WebBroker.

Open a New Account, or Login if you're a client.